|
Mar 12
|
Why Are Myriad Genetics (MYGN) Shares Soaring Today
|
|
Mar 11
|
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
|
|
Feb 27
|
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
|
|
Feb 26
|
Myriad Genetics Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 25
|
Why Myriad Genetics (MYGN) Shares Are Plunging Today
|
|
Feb 25
|
Myriad Genetics, Inc. (MYGN): AI-Driven Precision Medicine for Prostate Cancer
|
|
Feb 25
|
MYGN Q4 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down
|
|
Feb 25
|
Q4 2024 Myriad Genetics Inc Earnings Call
|
|
Feb 25
|
Myriad Genetics Inc (MYGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Feb 24
|
Myriad: Q4 Earnings Snapshot
|
|
Feb 24
|
Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops
|
|
Feb 24
|
Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth
|
|
Feb 24
|
Myriad Genetics Announces Senior Leadership Transition
|
|
Feb 24
|
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
|
|
Feb 23
|
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings
|
|
Feb 19
|
Myriad Genetics Included in Forbes America’s Best Employers 2025 List
|
|
Feb 18
|
Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
|
|
Feb 17
|
3 Reasons to Sell MYGN and 1 Stock to Buy Instead
|
|
Feb 11
|
MYGN Stock Might Rise on Collaboration With CancerCARE
|
|
Oct 9
|
Myriad signs five partnerships to study MRD testing in breast cancer
|